Skip to main content
Year archive

PRESCIENT THERAPEUTICS LIMITED — 2018 filings

All 41 regulatory filings released by PRESCIENT THERAPEUTICS LIMITED (PTX) in 2018, sourced directly from the official regulator.

41 Filings
2018 Period
2018 filings (41)
Filing Released Lang
Appendix 3B 12 pages 133.4KB
Capital/Financing Update
2018-12-18 English
Change of Director's Interest Notice 3 pages 41.7KB
Director's Dealing
2018-12-18 English
Change in substantial holding 2 pages 79.3KB
Regulatory Filings
2018-12-11 English
Interim Durability Analysis of PTX-200 Breast Cancer Study 3 pages 123.4KB
Regulatory Filings
2018-12-09 English
AGM Presentation 27 pages 2.2MB
AGM Information
2018-11-19 English
Results of Annual General Meeting 2 pages 614.9KB
Declaration of Voting Results & Voting Rights Announcements
2018-11-19 English
Change of Director's Interest Notices x3 6 pages 90.2KB
Director's Dealing
2018-11-08 English
September 2018 Appendix 4C - Quarterly 7 pages 165.7KB
Interim / Quarterly Report
2018-10-30 English
PTX Appoints Former Array BioPharma Executive to Key Role 3 pages 245.4KB
Board/Management Information
2018-10-28 English
Notice of Annual General Meeting/Proxy Form 16 pages 924.5KB
AGM Information
2018-10-18 English
Annual Report to Shareholders 54 pages 2.2MB
Annual Report
2018-10-18 English
Pipeline Collaboration for Next Generation Formulations 3 pages 245.0KB
Regulatory Filings
2018-10-16 English
Canadian Patent Granted for PTX-200 2 pages 238.6KB
Regulatory Filings
2018-09-23 English
Rodman & Renshaw Global Investment Conference Presentation 26 pages 1.9MB
Investor Presentation
2018-09-04 English
PTX to present at Rodman & Renshaw Investment conference 2 pages 240.3KB
Regulatory Filings
2018-09-03 English
Improved manufacturing route for PTX-100 3 pages 120.0KB
Regulatory Filings
2018-09-02 English
Release of Securities from Escrow 2 pages 116.7KB
Capital/Financing Update
2018-09-02 English
Appendix 4E and 2018 Annual Report 56 pages 1.8MB
Annual Report
2018-08-30 English
Appendix 4G and Corporate Governance Statement 23 pages 434.3KB
Governance Information
2018-08-30 English
PTX-200 AML Study Expanded 3 pages 244.4KB
Regulatory Filings
2018-08-29 English
Change in substantial holding 2 pages 133.3KB
Major Shareholding Notification
2018-08-14 English
June 2018 Appendix 4C - Quarterly 8 pages 450.4KB
Interim / Quarterly Report
2018-07-30 English
US Patent Granted for PTX-200 for Ovarian Cancer Treatment 3 pages 386.2KB
Regulatory Filings
2018-07-25 English
Change of Director's Interest Notices x2 5 pages 72.3KB
Director's Dealing
2018-07-05 English
Appendix 3B 12 pages 260.5KB
Capital/Financing Update
2018-07-04 English
PTXO Options Update 2 pages 130.6KB
Capital/Financing Update
2018-07-02 English
Appendix 3B 12 pages 239.4KB
Capital/Financing Update
2018-06-21 English
Letter to PTXO Option Holders 6 pages 1.5MB
Capital/Financing Update
2018-05-30 English
Section 708A Cleansing Notice and Appendix 3B 15 pages 264.9KB
Capital/Financing Update
2018-05-10 English
CSO Precision Medicine Presentation 39 pages 3.4MB
Investor Presentation
2018-04-30 English
March 2018 Appendix 4C - Quarterly 8 pages 447.8KB
Interim / Quarterly Report
2018-04-22 English
Response to Aware Query 5 pages 700.9KB
Regulatory Filings
2018-04-11 English
PTX-200 Phase 1b Breast Cancer Trial Results 5 pages 155.0KB
Regulatory Filings
2018-04-09 English
Appendix 3B 12 pages 513.8KB
Capital/Financing Update
2018-04-05 English
March 2018 Investor Presentation 34 pages 2.8MB
Investor Presentation
2018-03-18 English
Section 708A Cleansing Notice and Appendix 3B 15 pages 736.4KB
Capital/Financing Update
2018-03-13 English
Appendix 4D and Half Year Financial Report 20 pages 604.6KB
Interim / Quarterly Report
2018-02-26 English
Receipt of R&D Tax Rebate 2 pages 102.7KB
Regulatory Filings
2018-01-31 English
December 2017 Appendix 4C - Quarterly 8 pages 217.6KB
Interim / Quarterly Report
2018-01-30 English
Clinical Trial Updates 4 pages 109.7KB
Regulatory Filings
2018-01-28 English
Prescient Presenting at Biotech Showcase 2 pages 102.9KB
Investor Presentation
2018-01-09 English